Unihealth Hospitals Ltd. (UNIHEALTH) — Tipsheet https://tipsheet.markets/company/unihealth/ Every Tipsheet Editorial note covering Unihealth Hospitals Ltd. (UNIHEALTH), newest first. Grounded in BSE/NSE primary-source filings. en-in Tue, 28 Jul 2026 14:38:36 GMT Unihealth pushes 1,000-bed target to 2028, Uganda still 82% of revenue https://tipsheet.markets/unihealth-unihealth-pushes-1-000-bed-target-to-2028-uganda-still-82-of-revenue-117412/ https://tipsheet.markets/unihealth-unihealth-pushes-1-000-bed-target-to-2028-uganda-still-82-of-revenue-117412/ Tue, 30 Jun 2026 18:54:48 GMT Earlier commitments on geographic mix and a Tanzania syringe plant have been abandoned. EBITDA margins are set to compress from low-40s to mid-30s as new beds add costs. Earlier commitments on geographic mix and a Tanzania syringe plant have been abandoned. EBITDA margins are set to compress from low-40s to mid-30s as new beds add costs.

What’s new

  • 1,000-bed target delayed over two years; current base at 400 beds.
  • Uganda still 82% of revenue vs earlier goal of 25-30%.
  • Tanzania syringe plant abandoned; site repurposed for hospital beds.

Why it matters

Unihealth is walking away from two key earlier promises: geographic diversification and a non-hospital venture. Margins are set to compress from the low-40s to mid-30s, and PAT margin guidance for FY27 is just 8-10%. For a stock trading at 35x trailing earnings, execution credibility is now the open question.

What we’re watching

  • Whether the Dar es Salaam acquisition and Mwanza facility actually add 120 beds by 2028.
  • How quickly receivables improve in India vs Uganda's 320-day cycle.
  • Any further delays or abandonment of expansion plans.

The full read

Unihealth Hospitals has pushed its 1,000‑bed target from FY26 to the end of CY2028. Only 400 beds are commissioned today. Uganda still generated 82% of FY26 revenue, missing an earlier goal to cap any single geography at 25‑30%. A planned syringe plant in Tanzania has been scrapped — the Mwanza site will now be used for hospital beds instead. Promises are being abandoned one by one. Consolidated EBITDA margins are expected to fall from the low‑40s to the mid‑30s as new facilities burn cash, and PAT margin guidance for FY27 is just 8‑10%. The call outlined plans to add 120 beds in Tanzania via a Dar es Salaam acquisition and a secondary‑care facility in Mwanza, while improved payer mixes in India offer shorter receivables. But Uganda’s 320‑day receivable cycle remains a drag. With the stock already trading at 35x trailing earnings, each delay erodes the premium that relied on muscular growth assumptions — assumptions that the conference call systematically walked back.

Primary source: NSE

]]> Concalls Tipsheet Editorial Unihealth's Ugandan receivables hit 320 days; Tanzania plant scrapped https://tipsheet.markets/unihealth-unihealth-s-ugandan-receivables-hit-320-days-tanzania-plant-scrapped-105043/ https://tipsheet.markets/unihealth-unihealth-s-ugandan-receivables-hit-320-days-tanzania-plant-scrapped-105043/ Wed, 03 Jun 2026 13:23:10 GMT FY26 profit surged 83%, but the 1,000-bed expansion is now three years late and a key African bet has been abandoned. FY26 profit surged 83%, but the 1,000-bed expansion is now three years late and a key African bet has been abandoned.

What’s new

  • 1,000-bed expansion target pushed from FY25-26 to calendar 2028.
  • Uganda receivables days blew out to 320 from a prior 120-135.
  • Tanzania syringe manufacturing plan scrapped; replaced by a 20-bed clinic.

Why it matters

The core hospital business is delivering strong profit growth, but the international expansion story is unravelling. A receivable cycle of 320 days in Uganda is a serious cash-flow problem, and abandoning a promoted manufacturing facility without explanation raises governance questions. The revised bed expansion timeline delays the growth thesis by three years.

What we’re watching

  • Whether the Uganda receivables collection improves or becomes a write-down risk.
  • Regulatory approval for the 20-bed Mwanza facility in Tanzania.
  • Progress on the 100-bed Dar es Salaam acquisition, which is at final legal stages.

The full read

Unihealth Hospitals' FY26 numbers are strong. Revenue climbed 34.6% to ₹137 crore, margins expanded 400 bps to 42.9%, and profit surged 83%. But the conference call revealed several problems behind that headline. The 1,000-bed expansion, a key part of the growth story, is now delayed by three years to calendar 2028. In Uganda, receivable days have ballooned to 320 from a previously disclosed 120-135. That's nearly a year of unpaid bills. A serious cash-flow risk. In Tanzania, a previously promoted syringe manufacturing facility has been scrapped without explanation. Management is now pitching a 20-bed clinic in Mwanza and a 100-bed acquisition in Dar es Salaam. The domestic business is firing on all cylinders. The international footprint is generating operational headaches and governance questions. The next test is whether the Ugandan receivables collection problem becomes a write-down.

Primary source: NSE

]]> Concalls Tipsheet Editorial